
|Videos|June 24, 2016
Pharmacy Week in Review: June 24, 2016
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Advertisement
This weekly video program provides our readers with an in-depth review
of the latest news, product approvals, FDA rulings and more.
Featured article:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Updates in Treatment of Unresectable Hepatocellular Carcinoma
4
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
5









































































































































































































